Indian Company Master Data Made Simple
Venmax Drugs And Pharmaceuticals Limited
Incorporated in 1988, Venmax Drugs And Pharmaceuticals Limited has a history spanning 3 decades. Its CIN is L24230TG1988PLC009102, with registration number 9102. The organization is recorded as company limited by shares under Indian company law. Venmax Drugs And Pharmaceuticals Limited’s authorized capital amounts to ₹8.00 crore. The paid-up share capital amounts to ₹5.24 crore.
The main line of business is manufacture of chemicals and chemical products. The company’s registration location is Hyderabad. Its registered address is Shed No.22, Plot No.84, Phase - 1 Ida Cherlapally, Rangareddi, Hyderabad, Telangana, India, 500051. The firm continues to be in active status. The company’s official contact email is [email protected]. The leadership team includes Sai Baba Kummarikuntla (CFO).
Profile data last updated: 18/12/2024
Company Overview
- CIN
- Date of Incorporation
- 28/09/1988
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 31/03/2023
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹8,00,00,000.00
- Paid up Capital
- ₹5,23,89,300.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹0.10L | ₹0.46L | ₹0.47L | ₹0.46L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹75.77L | ₹73.15L | ₹92.59L | ₹115.37L | ₹0.00L |
| Accumulated Depreciation | -₹0.44L | -₹0.50L | -₹1.21L | -₹0.65L | ₹0.00L |
| Tangible Book Value | ₹441.15L | -₹67.49L | -₹73.75L | -₹96.55L | ₹0.00L |
| Long Term Debt | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹4.96L | ₹35.21L | ₹35.21L | ₹34.90L | ₹0.00L |
| Machinery Furniture Equipment | ₹4.49L | ₹5.00L | ₹6.21L | ₹6.21L | ₹0.00L |
| Total Assets | ₹516.96L | ₹8.14L | ₹21.14L | ₹21.36L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹441.19L | -₹65.01L | -₹71.45L | -₹94.01L | ₹0.00L |
| Gross PPE | ₹4.49L | ₹5.00L | ₹6.21L | ₹6.21L | ₹0.00L |
| Common Stock | ₹523.89L | ₹523.89L | ₹523.89L | ₹523.89L | ₹0.00L |
| Total Capitalization | ₹441.19L | -₹65.01L | -₹71.45L | -₹94.01L | ₹0.00L |
| Total Debt | ₹4.96L | ₹35.21L | ₹35.21L | ₹34.90L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹0.04L | ₹2.48L | ₹2.30L | ₹2.54L | ₹0.00L |
| Other Equity Interest | ₹507.25L | -₹588.90L | -₹595.34L | -₹617.90L | ₹0.00L |
| Capital Stock | ₹523.89L | ₹523.89L | ₹523.89L | ₹523.89L | ₹0.00L |
| Total Non Current Assets | ₹4.05L | ₹6.58L | ₹7.30L | ₹8.11L | ₹0.00L |
| Invested Capital | ₹446.15L | -₹29.80L | -₹36.24L | -₹59.11L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹248.24L | ₹0.25L | ₹0.03L | ₹0.03L | ₹0.00L |
| Net Tangible Assets | ₹441.15L | -₹67.49L | -₹73.75L | -₹96.55L | ₹0.00L |
| Cash And Cash Equivalents | ₹248.24L | ₹0.25L | ₹0.03L | ₹0.03L | ₹0.00L |
| Prepaid Assets | ₹161.00L | ₹0.00L | ₹10.17L | ₹9.58L | ₹0.00L |
| Stockholders Equity | ₹441.19L | -₹65.01L | -₹71.45L | -₹94.01L | ₹0.00L |
| Share Issued | ₹52.39L | ₹52.39L | ₹52.39L | ₹52.39L | ₹0.00L |
| Current Assets | ₹512.92L | ₹1.56L | ₹13.84L | ₹13.25L | ₹0.00L |
| Working Capital | ₹437.25L | -₹71.13L | -₹78.28L | -₹101.66L | ₹0.00L |
| Ordinary Shares Number | ₹52.39L | ₹52.39L | ₹52.39L | ₹52.39L | ₹0.00L |
| Current Debt | ₹4.96L | ₹35.21L | ₹35.21L | ₹34.90L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Liabilities | ₹75.67L | ₹72.69L | ₹92.12L | ₹114.91L | ₹0.00L |
| Retained Earnings | -₹589.95L | -₹588.90L | -₹595.34L | -₹690.93L | ₹0.00L |
| Net PPE | ₹4.05L | ₹4.50L | ₹5.00L | ₹5.56L | ₹0.00L |
| Common Stock Equity | ₹441.19L | -₹65.01L | -₹71.45L | -₹94.01L | ₹0.00L |
| Other Non Current Assets | -₹0.04L | -₹0.40L | ₹0.00L | ₹0.01L | ₹0.00L |
| Other Intangible Assets | ₹0.04L | ₹2.48L | ₹2.30L | ₹2.54L | ₹0.00L |
| Inventory | ₹5.75L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | ₹247.99L | ₹0.22L | ₹0.00L | -₹7.49L | ₹0.00L |
| Financing Cash Flow | ₹477.01L | ₹0.00L | ₹0.31L | -₹198.00L | ₹0.00L |
| Investing Cash Flow | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Free Cash Flow | -₹229.02L | ₹0.22L | -₹0.31L | ₹190.51L | ₹0.00L |
| End Cash Position | ₹248.24L | ₹0.25L | ₹0.03L | ₹0.03L | ₹0.00L |
| Beginning Cash Position | ₹0.25L | ₹0.03L | ₹0.03L | ₹7.53L | ₹0.00L |
| Operating Cash Flow | -₹229.02L | ₹0.22L | -₹0.31L | ₹190.51L | ₹0.00L |
| Issuance Of Capital Stock | ₹507.26L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Rent Expense Supplemental | ₹1.87L | ₹0.48L | ₹0.48L | ₹0.72L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | -₹1.05L | ₹6.45L | ₹22.56L | ₹184.62L | ₹0.00L |
| Basic EPS | -₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | -₹104.13L | -₹10.47L | ₹23.38L | ₹185.58L | ₹0.00L |
| Total Expenses | ₹185.50L | ₹11.19L | ₹19.36L | ₹13.64L | ₹0.00L |
| Total Unusual Items | -₹1.89L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Revenue | ₹80.73L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹0.48L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹1.89L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹0.08L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| General And Administrative Expense | ₹3.86L | ₹2.05L | ₹5.27L | ₹2.41L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | -₹1.05L | ₹6.45L | ₹22.56L | ₹184.62L | ₹0.00L |
| Reconciled Depreciation | ₹0.64L | ₹0.72L | ₹0.80L | ₹0.92L | ₹0.00L |
| Net Income Continuous Operations | -₹1.05L | ₹6.45L | ₹22.56L | ₹184.63L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹79.46L | ₹0.00L | ₹0.90L | ₹0.00L | ₹0.00L |
| Operating Income | -₹104.77L | -₹11.19L | -₹19.36L | -₹13.64L | ₹0.00L |
| Net Income | -₹1.05L | ₹6.45L | ₹22.56L | ₹184.62L | ₹0.00L |
| Diluted Average Shares | ₹52.39L | ₹52.39L | ₹52.39L | ₹52.39L | ₹0.00L |
| Selling And Marketing Expense | ₹0.68L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized Income | ₹0.36L | ₹6.45L | ₹22.56L | ₹184.62L | ₹0.00L |
| Total Other Finance Cost | ₹0.08L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.01L |
| Net Non Operating Interest Income Expense | -₹0.08L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹1.27L | ₹0.00L | -₹0.90L | ₹0.00L | ₹0.00L |
| EBIT | -₹104.77L | -₹11.19L | ₹22.57L | ₹184.66L | ₹0.00L |
| Cost Of Revenue | ₹79.46L | ₹0.00L | ₹0.90L | ₹0.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | -₹1.05L | ₹6.45L | ₹22.56L | ₹184.62L | ₹0.00L |
| Net Interest Income | -₹0.08L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | -₹102.24L | -₹10.47L | ₹23.38L | ₹185.58L | ₹0.00L |
| Operating Expense | ₹106.04L | ₹11.19L | ₹18.46L | ₹13.64L | ₹0.00L |
| Net Income Common Stockholders | -₹1.05L | ₹6.45L | ₹22.56L | ₹184.62L | ₹0.00L |
| Pretax Income | -₹1.41L | ₹8.69L | ₹22.57L | ₹184.66L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹80.73L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹4.54L | ₹2.05L | ₹5.27L | ₹2.41L | ₹0.00L |
| Other Operating Expenses | ₹94.95L | ₹5.69L | ₹9.36L | ₹8.40L | ₹0.00L |
| Diluted EPS | -₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹0.08L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹52.39L | ₹52.39L | ₹52.39L | ₹52.39L | ₹0.00L |
| Tax Provision | -₹0.36L | ₹2.24L | ₹0.01L | ₹0.03L | ₹0.00L |
| Net Income Including Noncontrolling Interests | -₹1.05L | ₹6.45L | ₹22.56L | ₹184.62L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 03/09/2015 | Nooka Krishnaiah | 07279009 | Managing Director | View other directorships |
| 16/01/2024 | Swapneswar Mishra | 09594775 | Additional Director | View other directorships |
| 16/01/2024 | Pilli Meena Kumari | 10458622 | Additional Director | View other directorships |
| 22/08/2024 | Dasi Reddy Rakesh | 07112785 | Additional Director | View other directorships |
| 22/08/2024 | Gundluru Reddeppa | 10419527 | Additional Director | View other directorships |
| 02/09/2024 | Sai Baba Kummarikuntla | *****4031H | CFO | |
| 02/09/2024 | Pratibha Jhawar | *****6013A | Company Secretary | |
| 01/10/2024 | Venkata Rao Sadhanala | 02906370 | Additional Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 25/11/2024 | Form AOC-4(XBRL)-22112024 | - |
| 14/11/2024 | Form MGT-7-14112024 | - |
| 12/11/2024 | Form MGT-7-28102024 | - |
| 10/11/2024 | Form AOC-4(XBRL)-02112024 | - |
| 16/10/2024 | Form MGT-7-01102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Shed No.22, Plot No.84, Phase - 1 Ida Cherlapally, Rangareddi, Hyderabad, Telangana, India, 500051
FAQ
What is the incorporation date of Venmax Drugs And Pharmaceuticals Limited?
The incorporation date of Venmax Drugs And Pharmaceuticals Limited is 28/09/1988.
Who are the current board members & directors of Venmax Drugs And Pharmaceuticals Limited?
The current board member of Venmax Drugs And Pharmaceuticals Limited are:
- Nooka Krishnaiah
- Swapneswar Mishra
- Pilli Meena Kumari
- Venkata Rao Sadhanala
- Dasi Reddy Rakesh
- Gundluru Reddeppa
What is the registered address of Venmax Drugs And Pharmaceuticals Limited?
The registered address of Venmax Drugs And Pharmaceuticals Limited is Shed No.22, Plot No.84, Phase - 1 Ida Cherlapally, Rangareddi, Hyderabad, Telangana, India, 500051.
What is the Corporate Identification Number of Venmax Drugs And Pharmaceuticals Limited?
The Corporate Identification Number of Venmax Drugs And Pharmaceuticals Limited is L24230TG1988PLC009102.